Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr;95(4):635-652.
doi: 10.1002/ana.26897. Epub 2024 Feb 27.

Role of the Exposome in Neurodegenerative Disease: Recent Insights and Future Directions

Affiliations
Review

Role of the Exposome in Neurodegenerative Disease: Recent Insights and Future Directions

Stacey A Sakowski et al. Ann Neurol. 2024 Apr.

Abstract

Neurodegenerative diseases are increasing in prevalence and place a significant burden on society. The causes are multifactorial and complex, and increasing evidence suggests a dynamic interplay between genes and the environment, emphasizing the importance of identifying and understanding the role of lifelong exposures, known as the exposome, on the nervous system. This review provides an overview of recent advances toward defining neurodegenerative disease exposomes, focusing on Parkinson's disease, amyotrophic lateral sclerosis, and Alzheimer's disease. We present the current state of the field based on emerging data, elaborate on key themes and potential mechanisms, and conclude with limitations and future directions. ANN NEUROL 2024;95:635-652.

PubMed Disclaimer

Conflict of interest statement

Potential Conflicts of Interest

The authors have no relevant conflicts to disclose.

Figures

Figure 1.
Figure 1.. The neural exposome.
The cumulative external and internal factors individuals are exposed to over the course of their lifetime. Exposures may interact with underlying genetic background (risk-modifying single-nucleotide polymorphisms represented by red shaded circles) to influence risk of neurodegenerative disease. Image created using BioRender.com.
Figure 2.
Figure 2.. Potential mechanisms by which air pollution influences risk of neurodegenerative disease.
Inhaled air pollution components access the brain directly through the olfactory system or indirectly through the blood stream and cause neurotoxicity and neuroinflammation. Airway epithelial cells trigger a systemic inflammatory response, which compromises the BBB. In the brain, components of air pollution induce oxidative stress, accumulation of proteins, e.g., β-amyloid and phosphorylated tau, and activates the hypothalamus-pituitary-adrenal axis. In the gut, air pollution changes the gut microbiome. Image created using BioRender.com.
Figure 3.
Figure 3.. Potential mechanisms by which OCPs influence risk of neurodegenerative disease.
OCPs cross the BBB and accumulate in lipid-rich brain tissue where they can affect neuronal function and survival through mitochondrial dysfunction, reactive oxygen species (ROS) production, oxidative stress, and microglial activation. OCP-induced histone hyperacetylation and genome-wide DNA methylation can also induce epigenetic dysregulation of gene expression. In AD, OCPs promote aggregation of β-amyloid and phosphorylated tau. In PD, OCPs disrupt dopamine synthesis, inhibit dopamine reuptake, and impact dopamine receptors and transporters. Image created using BioRender.com.
Figure 4.
Figure 4.. Potential mechanisms by which metal overexposure influences risk of neurodegenerative disease.
Essential metal dyshomeostasis or toxic metal accumulation induces reactive oxygen species (ROS) generation, which increases oxidative stress and impairs mitochondrial function. Dyshomeostasis of essential metals disrupts cellular processes. In addition, metal binding or metal-induced alterations in protein expression and activity facilitates accumulation of β-amyloid, phosphorylated tau, and α-synuclein. Metal overload promotes neural inflammation through microglial activation and production of proinflammatory cytokines. Image created using BioRender.com.

References

    1. Dorsey ER, Sherer T, Okun MS, Bloem BR. The Emerging Evidence of the Parkinson Pandemic. J Parkinsons Dis. 2018;8(s1):S3–S8. - PMC - PubMed
    1. Ou Z, Pan J, Tang S, et al. Global Trends in the Incidence, Prevalence, and Years Lived With Disability of Parkinson’s Disease in 204 Countries/Territories From 1990 to 2019. Front Public Health. 2021;9:776847. - PMC - PubMed
    1. Park J, Kim JE, Song TJ. The Global Burden of Motor Neuron Disease: An Analysis of the 2019 Global Burden of Disease Study. Front Neurol. 2022;13:864339. - PMC - PubMed
    1. Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019. Oct;32(5):771–6. - PMC - PubMed
    1. Collaborators GBDDF. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022. Feb;7(2):e105–e25. - PMC - PubMed